Live Clinical Webinar | Wednesday, April 29 · 12:00 PM ET
Persistent symptoms. Inconclusive results. Ongoing uncertainty.
Babesia is often considered in the clinical picture, yet it is not consistently recognized or detected. Variability in clinical presentation, pathogen biology, and diagnostic methods can make interpretation challenging, even when testing has been performed.
Featuring real clinical cases where Babesia was not identified through standard approaches.
Join us for a clinical webinar exploring why Babesia remains difficult to fully evaluate and how clinicians can better understand the gap between patient presentation and diagnostic results.
In this session, Jennifer C. Miller, PhD, Vice President of Clinical and Scientific Operations; CLIA Laboratory Technical Supervisor at Galaxy Diagnostics, will examine Babesia as a model for understanding diagnostic uncertainty in vector-borne disease.
Using real clinical cases, this webinar explores how symptom presentation, pathogen biology, research limitations, and diagnostic methods intersect to create complexity in detection and interpretation.
You’ll gain a clearer understanding of why results may not align with the clinical picture and how to approach these cases with greater confidence.
✔ Why Babesia may not be consistently detected, even when present.
✔ How parasitemia and organism behavior impact test sensitivity
✔ The difference between immune response (serology) and organism detection
✔ Why results may appear negative or discordant across methods
✔ How to interpret results within the context of clinical presentation
✔ What questions to ask when results do not match the clinical picture
This webinar is designed for:
✔ Clinicians managing chronic, persistent, or multisystem symptoms
✔ Providers evaluating patients with suspected vector-borne disease
✔ Integrative and functional medicine practitioners
✔ Healthcare professionals seeking clarity on diagnostic interpretation
This session is intended for clinicians and licensed healthcare providers only.
Patients may present with fatigue, cognitive dysfunction, dyspnea, and other systemic symptoms that are difficult to fully explain through standard diagnostic approaches.
In many cases, testing has been performed, yet results remain inconclusive or difficult to interpret.
Understanding how biology, detection, and methodology interact can help clinicians better navigate these cases and refine their diagnostic approach.
Access to the live webinar
Reminder emails and the live event link
On-demand replay following the session.
Downloadable presentation slides
Additional educational resources delivered via email
Galaxy Diagnostics advances the detection of elusive vector-borne pathogens through transparent, evidence-driven science, empowering clinicians to diagnose confidently in complex or uncertain presentations.
